This content is PDF only. Please click on the PDF icon to access.
In 50 chapters, the american medical association Council on Drugs and 280 consultants have provided most of the pertinent information on those single-entity drugs introduced during the past 10 years. The monographs occasionally read like expanded versions of a manufacturer's package "insert." However, the pattern is broken at the beginning of most chapters and sections by appropriate general discussions relating new to old drugs. The aims, format, binding, and price are quite acceptable.
Only the wording of certain precautions troubles this reviewer, especially those stating (frequently in italics) that the patient must be warned of certain hazards. By whom? Presumably
New Drugs.. Ann Intern Med. ;65:619–620. doi: 10.7326/0003-4819-65-3-619_2
Download citation file:
Published: Ann Intern Med. 1966;65(3):619-620.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use